Imaging corticotropin-releasing-factor and nociceptin in addiction and PTSD models

References

• Akana, S. F., Dallman, M. F., Bradbury, M. J., Scribner, K. A., Strack, A. M., & Walker, C. D. (1992). Feedback and facilitation in the adrenocortical system: unmasking facilitation by partial inhibition of the glucocorticoid response to prior stress. Endocrinology, 131, 57–68. doi:10.1210/endo.131.1.1319329
   PubMed Web of Science ®Google Scholar
• Andero, R., Brothers, S. P., Jovanovic, T., Chen, Y. T., Salah-Uddin, H., Cameron, M., … Ressler, K. J. (2013). Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Science Translational Medicine, 5, 188ra173. doi:10.1126/scitranslmed.3005656
   Web of Science ®Google Scholar
• Baur, V., Hanggi, J., Langer, N., & Jancke, L. (2013). Resting-state functional and structural connectivity within an insula-amygdala route specifically index state and trait anxiety. Biological Psychiatry, 73, 85–92. doi:10.1016/j.biopsych.2012.06.003
   PubMed Web of Science ®Google Scholar
• Berenz, E. C., & Coffey, S. F. (2012). Treatment of co-occurring posttraumatic stress disorder and substance use disorders. Current Psychiatry Reports, 14, 469–477. doi:10.1007/s11920-012-0300-0
   PubMed Web of Science ®Google Scholar
• Berthele, A., Platzer, S., Dworzak, D., Schadrack, J., Mahal, B., Buttner, A., … Tolle, T. R. (2003). [3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain. Neuroscience, 121, 629–640.
   PubMed Web of Science ®Google Scholar
• Bornhovd, K., Quante, M., Glauche, V., Bromm, B., Weiller, C., & Buchel, C. (2002). Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain, 125, 1326–1336. doi:10.1093/brain/awf137
   PubMed Web of Science ®Google Scholar
• Bridge, K. E., Wainwright, A., Reilly, K., & Oliver, K. R. (2003). Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience, 118, 513–523. doi:10.1016/S0306-4522(02)00927-2
   PubMed Web of Science ®Google Scholar
• Ciccocioppo, R., de Guglielmo, G., Hansson, A. C., Ubaldi, M., Kallupi, M., Cruz, M. T., … Roberto, M. (2014). Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors. Journal of Neuroscience, 34, 363–372. doi:10.1523/JNEUROSCI.2400-13.2014
   PubMed Web of Science ®Google Scholar
• Ciccocioppo, R., Economidou, D., Fedeli, A., Angeletti, S., Weiss, F., Heilig, M., & Massi, M. (2004). Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl), 172, 170–178. doi:10.1007/s00213-003-1645-1
   PubMed Web of Science ®Google Scholar
• Ciccocioppo, R., Fedeli, A., Economidou, D., Policani, F., Weiss, F., & Massi, M. (2003). The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. Journal of Neuroscience, 23, 9445–9451.
   PubMed Web of Science ®Google Scholar
• Ciccocioppo, R., Panocka, I., Polidori, C., Regoli, D., & Massi, M. (1999). Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl), 141, 220–224. doi:10.1007/s002130050828
   PubMed Web of Science ®Google Scholar
• Ciccocioppo, R., Polidori, C., Antonelli, L., Salvadori, S., Guerrini, R., & Massi, M. (2002). Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides, 23, 117–125. doi:10.1016/S0196-9781(01)00587-3
   PubMed Web of Science ®Google Scholar
• Cook, C. J. (2004). Stress induces CRF release in the paraventricular nucleus, and both CRF and GABA release in the amygdala. Physiology & Behavior, 82, 751–762. doi:10.1016/j.physbeh.2004.06.013
   PubMed Web of Science ®Google Scholar
• Delaney, G., Dawe, K. L., Hogan, R., Hunjan, T., Roper, J., Hazell, G., … Fulford, A. J. (2012). Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats. Journal of Neuroendocrinology, 24, 1527–1541. doi:10.1111/j.1365-2826.2012.02361.x
   PubMed Web of Science ®Google Scholar
• Economidou, D., Fedeli, A., Fardon, R. M., Weiss, F., Massi, M., & Ciccocioppo, R. (2006). Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides, 27, 3299–3306. doi:10.1016/j.peptides.2006.09.007
   PubMed Web of Science ®Google Scholar
• Economidou, D., Hansson, A. C., Weiss, F., Terasmaa, A., Sommer, W. H., Cippitelli, A., … Heilig, M. (2008). Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biological Psychiatry, 64, 211–218. doi:10.1016/j.biopsych.2008.02.004
   PubMed Web of Science ®Google Scholar
• Enman, N. M., Zhang, Y., & Unterwald, E. M. (2014). Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides. Pharmacology Biochemistry and Behavior, 117, 61–69. doi:10.1016/j.pbb.2013.12.001
   PubMed Web of Science ®Google Scholar
• Furay, A. R., Bruestle, A. E., & Herman, J. P. (2008). The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology, 149, 5482–5490. doi:10.1210/en.2008-0642
   PubMed Web of Science ®Google Scholar
• Herman, J. P., & Mueller, N. K. (2006). Role of the ventral subiculum in stress integration. Behavioural Brain Research, 174, 215–224. doi:10.1016/j.bbr.2006.05.035
   PubMed Web of Science ®Google Scholar
• Hostetler, E. D., Sanabria-Bohorquez, S., Eng, W., Joshi, A. D., Patel, S., Gibson, R. E., … Hargreaves, R. J. (2013). Evaluation of [(1)(8)F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human. NeuroImage, 68, 1–10. doi:10.1016/j.neuroimage.2012.11.053
   PubMed Web of Science ®Google Scholar
• Jenck, F., Moreau, J. L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., Jr., … Civelli, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences of the United States of America, 94, 14854–14858.
   PubMed Web of Science ®Google Scholar
• Kenakin, T. (2011). Functional selectivity and biased receptor signaling. Journal of Pharmacology and Experimental Therapeutics, 336, 296–302. doi:10.1124/jpet.110.173948
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593–602. doi:10.1001/archpsyc.62.6.593
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Birnbaum, H., Demler, O., Falloon, I. R., Gagnon, E., Guyer, M., … Wu, E. Q. (2005). The prevalence and correlates of nonaffective psychosis in the national comorbidity survey replication (NCS-R). Biological Psychiatry, 58, 668–676. doi:10.1016/j.biopsych.2005.04.034
   PubMed Web of Science ®Google Scholar
• Kimura, Y., Fujita, M., Hong, J., Lohith, T. G., Gladding, R. L., Zoghbi, S. S., … Innis, R. B. (2011). Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors. Journal of Nuclear Medicine, 52, 1638–1645. doi:10.2967/jnumed.111.091181
   PubMed Web of Science ®Google Scholar
• Koob, G. F. (2004). Allostatic view of motivation: implications for psychopathology. Nebraska Symposium on Motivation, 50, 1–18.
   PubMed Web of Science ®Google Scholar
• Koob, G. F. (2008). A role for brain stress systems in addiction. Neuron, 59, 11–34. doi:10.1016/j.neuron.2008.06.012
   PubMed Web of Science ®Google Scholar
• Koob, G. F. (2009). Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology, 56(Suppl 1), 18–31. doi:10.1016/j.neuropharm.2008.07.043
   PubMed Web of Science ®Google Scholar
• Koob, G. F., & Heinrichs, S. C. (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Research, 848, 141–152. doi:10.1016/S0006-8993(99)01991-5
   PubMed Web of Science ®Google Scholar
• Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97–129. doi:10.1016/S0893-133X(00)00195-0
   PubMed Web of Science ®Google Scholar
• Koster, A., Montkowski, A., Schulz, S., Stube, E. M., Knaudt, K., Jenck, F., … Reinscheid, R. K. (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 10444–10449.
   PubMed Web of Science ®Google Scholar
• Kuzmin, A., Bazov, I., Sheedy, D., Garrick, T., Harper, C., & Bakalkin, G. (2009). Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain Research, 1305(Suppl), S80–S85. doi:10.1016/j.brainres.2009.05.067
   PubMed Web of Science ®Google Scholar
• LeDoux, J. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155–184. doi:10.1146/annurev.neuro.23.1.155
   PubMed Web of Science ®Google Scholar
• Leggett, J. D., Harbuz, M. S., Jessop, D. S., & Fulford, A. J. (2006). The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats. Neuroscience, 141, 2051–2057. doi:10.1016/j.neuroscience.2006.05.036
   PubMed Web of Science ®Google Scholar
• Leggett, J. D., Jessop, D. S., & Fulford, A. J. (2007). The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm. Neuroscience, 147, 757–764. doi:10.1016/j.neuroscience.2007.04.010
   PubMed Web of Science ®Google Scholar
• Lodge, N. J., Li, Y. W., Chin, F. T., Dischino, D. D., Zoghbi, S. S., Deskus, J. A., … Pike, V. W. (2014). Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors. Nuclear Medicine and Biology, 41, 524–535. doi:10.1016/j.nucmedbio.2014.03.005
   PubMed Web of Science ®Google Scholar
• Lohith, T. G., Zoghbi, S. S., Morse, C. L., Araneta, M. D., Barth, V. N., Goebl, N. A., … Fujita, M. (2014). Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans. Neuroimage, 87, 89–95. doi:10.1016/j.neuroimage.2013.10.068
   PubMed Web of Science ®Google Scholar
• Lohith, T. G., Zoghbi, S. S., Morse, C. L., Araneta, M. F., Barth, V. N., Goebl, N. A., … Fujita, M. (2012). Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A. Journal of Nuclear Medicine, 53, 385–392. doi:10.2967/jnumed.111.097162
   PubMed Web of Science ®Google Scholar
• Mallimo, E. M., & Kusnecov, A. W. (2013). The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation. Frontiers in Cellular Neuroscience, 7, 173. doi:10.3389/fncel.2013.00173
   PubMed Web of Science ®Google Scholar
• Martin-Fardon, R., Ciccocioppo, R., Massi, M., & Weiss, F. (2000). Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport, 11, 1939–1943. doi:10.1097/00001756-200006260-00026
   PubMed Web of Science ®Google Scholar
• Narendran, R., Ciccocioppo, R., Lopresti, B., Paris, J., Himes, M. L., & Mason, N. S. (2017). Nociceptin receptors in alcohol use disorders: a positron emission tomography study using [11C]NOP-1A. Biological Psychiatry, doi:10.1016/j.biopsych.2017.05.019
   PubMedGoogle Scholar
• Neugebauer, V., Li, W., Bird, G. C., & Han, J. S. (2004). The amygdala and persistent pain. Neuroscientist, 10, 221–234. doi:10.1177/1073858403261077
   PubMed Web of Science ®Google Scholar
• Pike, V. W., Rash, K. S., Chen, Z., Pedregal, C., Statnick, M. A., Kimura, Y., … Innis, R. B. (2011). Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography. Journal of Medicinal Chemistry, 54, 2687–2700. doi:10.1021/jm101487v
   PubMed Web of Science ®Google Scholar
• Post, A., Smart, T. S., Jackson, K., Mann, J., Mohs, R., Rorick-Kehn, L., … Wong, C. J. (2016). Proof-of-concept study to assess the nociceptin receptor antagonist LY2940094 as a new treatment for alcohol dependence. Alcoholism: Clinical and Experimental Research, 40, 1935–1944. doi:10.1111/acer.13147
   PubMed Web of Science ®Google Scholar
• Raddad, E., Chappell, A., Meyer, J., Wilson, A., Ruegg, C. E., Tauscher, J., … Verfaille, S. J. (2016). Occupancy of Nociceptin/Orphanin FQ peptide receptors by the antagonist LY2940094 in rats and healthy human subjects. Drug Metabolism & Disposition, 44, 1536–1542. doi:10.1124/dmd.116.070359
   PubMedGoogle Scholar
• Recker, M. D., & Higgins, G. A. (2004). The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5] decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue. Journal of Pharmacology and Experimental Therapeutics, 311, 652–658. doi:10.1124/jpet.104.071423
   PubMed Web of Science ®Google Scholar
• Rodi, D., Zucchini, S., Simonato, M., Cifani, C., Massi, M., & Polidori, C. (2008). Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl), 196, 523–531. doi:10.1007/s00213-007-0985-7
   PubMed Web of Science ®Google Scholar
• Rorick-Kehn, L. M., Ciccocioppo, R., Wong, C. J., Witkin, J. M., Martinez-Grau, M. A., Stopponi, S., … Statnick, M. A. (2016). A novel, orally bioavailable nociceptin receptor antagonist, LY2940094, reduces ethanol self-administration and ethanol seeking in animal models. Alcoholism: Clinical and Experimental Research, 40, 945–954. doi:10.1111/acer.13052
   PubMed Web of Science ®Google Scholar
• Saladin, M. E., Drobes, D. J., Coffey, S. F., Dansky, B. S., Brady, K. T., & Kilpatrick, D. G. (2003). PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime. Addictive Behaviors, 28, 1611–1629. doi:10.1016/j.addbeh.2003.08.037
   PubMed Web of Science ®Google Scholar
• Sledjeski, E. M., Speisman, B., & Dierker, L. C. (2008). Does number of lifetime traumas explain the relationship between PTSD and chronic medical conditions? Answers from the National Comorbidity Survey-Replication (NCS-R). Journal of Behavioral Medicine, 31, 341–349. doi:10.1007/s10865-008-9158-3
   PubMed Web of Science ®Google Scholar
• Smith, S. M., & Vale, W. W. (2006). The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience, 8, 383–395.
   PubMedGoogle Scholar
• Sra, J., Bremner, S., Krum, D., Dhala, A., Blanck, Z., Deshpande, S., … Akhtar, M. (1997). The effect of biphasic waveform tilt in transvenous atrial defibrillation. Pacing and Clinical Electrophysiology, 20, 1613–1618.
   PubMed Web of Science ®Google Scholar
• Stein, M. B., Simmons, A. N., Feinstein, J. S., & Paulus, M. P. (2007). Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. The American Journal of Psychiatry, 164, 318–327. doi:10.1176/ajp.2007.164.2.318
   PubMed Web of Science ®Google Scholar
• Sullivan, G. M., Parsey, R. V., Kumar, J. S., Arango, V., Kassir, S. A., Huang, Y. Y., … Mann, J. J. (2007). PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density?. Nuclear Medicine and Biology, 34, 353–361. doi:10.1016/j.nucmedbio.2007.01.012
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai, Y. M., & Herman, J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nature Reviews Neuroscience, 10, 397–409. doi:10.1038/nrn2647
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai, Y. M., Ostrander, M. M., Thomas, I. M., Packard, B. A., Furay, A. R., Dolgas, C. M., … Herman, J. P. (2007). Daily limited access to sweetened drink attenuates hypothalamic-pituitary-adrenocortical axis stress responses. Endocrinology, 148, 1823–1834. doi:10.1210/en.2006-1241
   PubMed Web of Science ®Google Scholar
• Vitale, G., Arletti, R., Ruggieri, V., Cifani, C., & Massi, M. (2006). Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides, 27, 2193–2200. doi:10.1016/j.peptides.2006.04.003
   PubMed Web of Science ®Google Scholar
• Weiss, N. H., Tull, M. T., Anestis, M. D., & Gratz, K. L. (2013). The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients. Drug and Alcohol Dependence, 128, 45–51. doi:10.1016/j.drugalcdep.2012.07.017
   PubMed Web of Science ®Google Scholar
• Yamamoto, S., Morinobu, S., Takei, S., Fuchikami, M., Matsuki, A., Yamawaki, S., & Liberzon, I. (2009a). Single prolonged stress: toward an animal model of posttraumatic stress disorder. Depression and Anxiety, 26, 1110–1117. doi:10.1002/da.20629
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., Miyazaki, R., & Yamada, T. (2009b). Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test. Peptides, 30, 1683–1688. doi:10.1016/j.peptides.2009.05.027
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Simpson-Durand, C. D., & Standifer, K. M. (2015). Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. British Journal of Pharmacology, 172, 571–582. doi:10.1111/bph.12701
   PubMed Web of Science ®Google Scholar